Multivessel percutaneous coronary intervention: A new paradigm for a new century

Minerva Cardioangiologica

Volumn 53, Issue 5, 2005, Pages 361-377

  Morrison, D A ^a,b  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Coronary bypass; Myocardial infarction; Percutaneous coronary interventions; Stents

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METAL; THIENOPYRIDINE; THROMBIN INHIBITOR; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANGINA PECTORIS; BRAIN DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; DRUG ELUTING STENT; HEALTH CARE COST; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; LIVER DISEASE; LUNG DISEASE; MEDICAL SOCIETY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; RESTENOSIS; REVIEW; RIGHT CORONARY ARTERY; ST SEGMENT ELEVATION; STENT; SURVIVAL TIME; SYMPTOMATOLOGY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FORECASTING; HUMANS; STENTS;

EID: 28444442329     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (245)

1. Morrison DA, Sacks J. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lessons from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery. Minerva Cardioangiol 2003;51: 585-97.
2. Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ et al. ACC/AHA Guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to revise the 1993 Guidelines for Percutaneous Coronary Transluminal Angioplasty). J Am Coll Cardiol 2001;37: 2239i-lxvi.
3. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: 1999 update: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999;34:890-911.
4. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on the management of patients with Unstable Angina). J Am Coll Cardiol 2000;36:970-1062.
5. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: summary article; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (Committee on the management of patients with Unstable Angina). J Am Coll Cardiol 2002;40:1366-74.
6. Guidelines and indications for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 1991;17:543-89.
7. Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ et al. ACC/AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). T Am Coll Cardiol 1999;34:1262-346.
8. King SB, McCallister BD, Smith SC, Ullyot DJ. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1993;22:2033-54.
9. Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ et al. ACC/AHA Guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to revise the 1993 Guidelines for Percutaneous Coronary Transluminal Angioplasty). J Am Coll Cardiol 2001;37: 2239i-lxvi.
10. Morrison DA, Sacks J, Barbiere CC, Sethi G. PTCA comes to the bifurcations in the road: what the VA has to offer. J Am Coll Cardiol 1997;29:1512-4.
11. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven year survival in the Veterans Administrations randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984;319:332-7.
12. Varnauskas E and the European Coronary Surgery Study Group. Twelve-year follow-up of survival in the randomized European Coronary Surgery study. N Engl J Med 1988;319:332-7.
13. Coronary Artery Surgery Study (CASS): a randomized trial of coronary bypass surgery. Survival data. Circulation 1983;68:939-50.
14. Luchi RJ, Scott SM, Deupree RH and the Principal Investigators and their Associates of Veterans Administration Cooperative Study No 28. Comparison of medical and surgical treatment for unstable angina pectoris. N Engl J Med 1987;316:977-84.
15. Scott SM, Luchi RJ, Deupree RH and the Veterans Administration Unstable Angina Cooperative Study Group. Veterans Administration Cooperative Study for treatment of patients with unstable angina. Circulation 1988;78 Suppl I:I-113-I-121.
16. Parisi AF, Khuri S, Deupree RH, Sharma GVRK, Scott SM, Luchi RJ. Medical compared with surgical management of unstable angina. 5- year mortality and morbidity in the Veterans Administration Study. Circulation 1989;80:1176-89.
17. Unstable angina pectoris: national cooperative study group to compare medical and surgical therapy I. Report of protocol and patient population. Am J Cardiol 1976;37:896-902.
18. Unstable angina pectoris: national cooperative study group to compare surgical and medical therapy II. In-hospital experience and initial follow-up results in patients with one, two, and three vessel disease. Am J Cardiol 1978;42:839-48.
19. Morrison DA, Sacks J. What constitutes medically refractory in the new millennium? In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz; 2002. p.11-24.
20. Antiplatelet Trialists Collaboration. Collaborative overview of randomized trials of antiplatelet therapy-I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1995;308:81-106.
21. Larosa JC, Hunninghake D, Bush D, Criqui MH, Getz GS, Gotto AM Jr et al. The cholesterol facts: a summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association. Circulation 1998;97:946-52.
22. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progr Cardiovasc Dis 1985;27: 535-71.
23. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988;260:2259-63.
24. ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. Circulation 1998;97:2202.
25. Parisi AF, Folland ED, Hartigan P, on behalf of the Veterans Affairs ACME Investigators. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-6.
26. RITA-2 trial Participants. Coronary angioplasty versus medical therapy for angina: the second Randomized Intervention Treatment of Angina (RITA-2) Trial. Lancet 1997;350:461-8.
27. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM et al. for the Atorvastatin Versus Revascularization Treatment Investigators. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999;341:70-6.
28. Bourassa MG, Knatterud GL, Pepine CJ, Sopko G, Rogers WJ, Geller NL et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Improvement of cardiac ischemia at 1 year after PTCA and CABG. Circulation 1995;92 (9 Suppl):II1-7.
29. Pfisterer M, Buser P, Osswald S, Allenmann W, Amann W, Angehrn W et al. for the Trial of Invasive versus Medical Therapy in Elderly patients (TIME) investigators. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy. One-year results of the randomized TIME Trial. JAMA 2003;289:1117-23.
30. rd. Randomized trials of percutaneous transluminal coronary angioplasty, coronary artery bypass grafting surgery, or medical therapy in patients with coronary artery disease. Cor Art Dis 1990;1:449-54.
31. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993;341:573-80.
32. CABRI Trial Participants. First Year Results of CABRI (Coronary Angioplasty vs Bypass Revascularization Investigation). Lancet 1995;346:1179-84.
33. rd, Lembo NJ, Kosinski AS, Kosinski AS, Barnhart HX, Kutner MH et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994;331:1044-50.
34. Hamm CW, Riemers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multi-vessel coronary disease. N Engl J Med 1994;331:1037-43.
35. Rodriguez A, Boullon F, Perez-Balino N, Paviotti C, Liprandi MI, Palacios IF. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multi-vessel disease (ERACI): in-hospital results and 1 year follow-up. J Am Coll Cardiol 1993;22:1060-7.
36. BARI Investigators. Protocol for the Bypass Angioplasty Revascularization Investigation. Circulation 1991;84 Suppl V:1-27.
37. rd, Sopko G, Detre KM. A symposium: multi-vessel PTCA versus CABG: Baseline Data from the Bypass Angioplasty Revascularization Investigation (BARI) and the Emory Angioplasty Surgery Trial (EAST). Am J Cardiol 1995;75:1c-59c.
38. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344: 563-70.
39. rd, Hamm CW et al. Meta-analysis of randomized trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346:1184-9.
40. Sim I, Gupta M, McDonald K, Bourassa M, Hlatky MA. A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multi-vessel coronary artery disease. Am J Cardiol 1995;76:1025-9.
41. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Circulation 1994;89: 1545-56.
42. Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG et al. for the Veterans affairs Non-Q-Wave Infarction Strategies in Hospital (VAN-QWISH) Trial Investigators. Outcomes in patients with acute non-Q-Wave myocardial infarction randomly assigned to an invasive strategy as compared with a conservative management strategy. N Engl J Med 1998;338:1785-92.
43. Fragmin and Fast Revascularization during instability in Coronary Artery Disease Investigators. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomized multicentre study. Lancet 1999;3554:708-15.
44. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N et al. for the TACTICS-Thrombolysis in Myocardial Infarction 18 investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary Syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87.
45. Fox KAA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR et al. for the Randomized Intervention Trial of unstable Angina (RITA) Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomized trial. Lancet 2002;360: 743-51.
46. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 2003;361:13-20.
47. Zijlstra F, de Boer MJ, Hormtje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
48. Ribeiro EE, Silva LA, Carneiro R, D'Oliveira LG, Gasquez A, Amino JG et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 1993;22:376-80.
49. Grinfeld L, Berrocal D, Belardi J, Spinetta A, Rojas Matas C, Oberti P et al. Fibrinolytics vs primary angioplasty in acute myocardioa infarction (FAP): a randomized trial in a community hospital in Argentina. J Am Coll Cardiol 1996;27 Suppl:A222.
50. Zijlstra F, Beukema WP, van't Hof AW, Liem A, Reiffers S, Hoorntje JC et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol 1997;29:908-12.
51. Akhras F, Abu Ousa A, Swann G et al. Primary coronary angioplasty or intravenous thrombolysis for patients with acute myocardial infarction? Acute and late follow-up results in a cardiac care unit. J Am Coll cardiol 1997; 29 Suppl:A235-6.
52. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to community hospital without a catheterization laboratory: the PRAGUE study. Eur Heart J 2000;21:823-31.
53. de Boer MJ, Ottervanger JP, van't Hof AW, Hoorntje JC, Suryapranata H, Zijlstra F. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol 2002;39: 1723-8.
54. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9.
55. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993;328:685-91.
56. Ribichini F, Steffenino G, Dellavalle A, Ferrero V, Vado A, Feola M et al. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. J Am Coll Cardiol 1998;32:1687-94.
57. Garcia E, Elizaga J, Soriano J, Serrano JA, Soriano J, Abeytua M et al. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. J Am Coll Cardiol 1999;33:605-11.
58. The Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997;336:1621-8.
59. Le May MR, Labinaz M, Davies RF, Marquis JF, Laramee LA, O'Brien ER et al. Stenting versus thrombolysis in acute myocardial infarction (STAT). J Am Coll Cardiol 2001;37:985-91.
60. Bonnefoy E, Lapostelle F, Leizoroviccz A, Steg G, McFadden EP, Dubien PY et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction; a randomized study. Lancet 2002;360:825-9.
61. Schomig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 2000;343:385-91.
62. Vermeer F, Oude Ophuis AJ, van den Berg EJ, Brunninkhuis LG, Werter CJ, Boehmer AG et al. Prospective randomized comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart 1999;82:426-31.
63. Andersen H, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H. Thayssen P et al. for the DANAMI-2 investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-42.
64. Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J et al. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomized trial. Lancet 2002;359:920-5.
65. Aversano T, Aversano LT, Passamani E, Knatterud GL, Terrin ML, Williams DO et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA 2002;287:1943-51.
66. Grines CL, Westerhausen DR, Grines LL, Hanlon JT, Logemann TL, Niemela M et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction. J Am Coll Cardiol 2002;39:1713-9.
67. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999;341:625-34.
68. Weaver WD, Simes J, Betrieu A, Grines CL, Zijlstra F, Garcia E et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. A quantitative review. JAMA 1997;278:2093-8.
69. Every NR, Maynard C, Cochran RP, Martin J, Weaver WD, for the Myocardial Infarction Triage and Intervention Investigators. Characteristics, management, and outcome of patients treated with acute myocardial infarction treated with bypass surgery. Circulation 1996;94 Suppl II:II81-6.
70. Stone GW, Brodie BR, Grines L, Boura J, O'Neill WW, Grines CL for the Primary Angioplasty in Myocardial Infarction Trial-2 (PAMI-2) Investigators. Role of cardiac surgery in the hospital phase of management of patients treated with primary angioplasty for acute myocardial infarction. Am J Cardiol 2000;85:1292-6.
71. Morrison DA, Sethi G, Sacks J, Grover F, Sedlis S, Esposito R et al. A multi-center, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. Control Clin Trials 1999;20:601-19.
72. Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischenia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. J Am Coll Cardiol 2001;38:143-9.
73. Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S et al. A multi-center, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The VA AWESOME multicenter registry: comparison with the randomized clinical trial. J Am Coll Cardiol 2002;39:266-73.
74. Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S et al. for the Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia AWESOME randomized trial and registry experience with postCABG patients. J Am Coll Cardiol 2002;40:1951-4.
75. Sedlis S, Morrison DA, Lorin J, Esposito R, Sethi G, Sacks J et al., for the Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass; outcome of diabetic patients in the AWESOME randomized trial and registry. J Am Coll Cardiol 2002;40:1555-66.
76. Morrison DA, Sacks J, Henderson W, Sethi G. The AWESOME Trial. In: Morrison DA. Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz; 2002.p.217-34.
77. Hannan EL, Raez MJ, McCallister BD, Ryan TJ, Arani DT. Isom OW et al. A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1999;33:63-72.
78. Jones RH, Kesler K, Phillips HR 3rd, Mark DK, Smith PK, Nelson CL et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg 1996;111:1013-5.
79. Best PJM, Berger PB. Can percutaneous coronary interventions reduce death and myocardial infarction in stable and unstable coronary disease? Catheter Cardiovasc Interv 2004;61:528-36.
80. Rodriguez A. Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J et al. Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. J Am Coll Cardiol 2001;37:51-8.
81. Ryan TJ. Present-day PTCR versus CABG: a randomized comparison with a different focus and a new result. J Am Coll Cardiol 2001;37:59-62.
82. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP et al. for the Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-24.
83. Serruys PW, Unger F, van Hout BA et al. for the ARTS study group. The ARTS (Arterial Revascularization Therapies Study): background, goals and methods. Int J Cardiovasc Interv 1999;2:41-50.
84. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomized controlled trial. Lancet 2002;360:965-70.
85. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 2003;107:2998-3002.
86. Rihal CS, Raco DL, Gersh BJ, Yusuf S. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. Circulation 2003;108:2439-45.
87. Mathew V, Gersh BJ, Williams BA, Laskey WA, Willerson JT, Tilbury RT et al. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial. Circulation 2004;109:476-80.
88. Brener SJ, Lytle BW, Casserly IP, Schneider JP, Topol EJ, Lauer MS. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 2004;109:2290-5.
89. Moushmoush B, Kramer B, Hsieh AM, Klein LW. Does the AHA/ACC task force grading system predict outcome in multivessel coronary angioplasty? Catheter Cardiovasc Diagn 1992;27:97-105.
90. Tan K, Sulke N, Tauh N, Sowton E. Clinical and lesion morphologic determinants of coronary angioplasty success and complications; current experience. J Am Coll Card 1995;25:855-65.
91. Hong MK, Popma JJ, Baim DS, Ywh W, Detre KM, Leon MB. Frequency and predictors of major in-hospital complications after planned and unplanned new-device angioplasty from the New Approaches to Coronary Intervention (NACI) Registry. Am J Cardiol 1997;80(10A):40K-9K.
92. Saucedo JF, Popma JJ, Kennard ED, Talley DJ, Lansky A, Leon MB et al. Relation of coronary artery size to one-year clinical events after new device angioplasty of native coronary arteries (A New Approach to Coronary Intervention [NACI] Registry Report). Am J Cardiol 2000;85:166-71.
93. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angio-plasty Prognosis Study Group. Circulation 1990;82:1193-202.
94. Mathew V, Grill DE, Scott CG, Garrett KN, Homes DR Jr. Baseline clinical and angiographic variables associated with long-term outcome after successful intracoronary stent implantation. Am J Cardiol 1999;84:789-94.
95. Krone RJ, Laskey WK, Johnson C, Kimmel SE, Klein LW, Weiner BH et al. for the Registry Committee of the Society for Cardiac Angiography and Interventions. A simplified lesion classification for predicting success and complications of coronary angioplasty. Am J Cardiol 2000;85:1179-84.
96. Krone RJ, Kimmel SE, Laskey WK, Klein LW, Schectman KB, Constentino AJJ et al. for the Registry Committee of the Society for Cardiac Angiography and Interventions. Evaluation of the Society for Cardiac Angiography and Interventions' Lesion Classification System in 14,133 patients with percutaneous coronary interventions in the current stent era. Catheter Cardiovasc Interv 2002;55:1-7.
97. Wilensky RL, Selzer F, Johnston J, Laskey WK, Klugherz BD, Block P et al. Relation of percutaneous coronary intervention of complex lesions to clinical outcomes (from the NHLBI Dynamic Registry). Am J Cardiol 2002;90:216-21.
98. Ashby DT, Dangas G, Mehran R, Leon MB. Coronary artery stenting. Catheter Cardiovasc Interv 2002;56:83-102
99. Phillips PSA, Kern MJ, Serruys PW. The Stenter's Notebook. Birmingham, Michigan: Physician's Press; 1998.
100. Davidson CJ, Ricciardi MJ. Complex Angioplasty. In: Nissen SE, editor. CATHSAP II Clinical Applications in Coronary Artery Disease. American College of Cardiology and Society for Cardiac Angiography and Interventions; 2001. p. 53-59.
101. Goudreau E. Long lesions and diffuse disease. In: Nissen SE, editor. CATHSAP II Clinical Applications in Coronary Artery Disease. American College of Cardiology and Society for Cardiac Angiography and Interventions; 2001. p. 87-92.
102. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G et al. for the BENESTENT Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331:489-95.
103. Fischman DL, Leon MB, Bairn DS, Schatz RA, Savage MP, Penn I et al. for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
104. Holmes DR, Garrett KN, Popma J. Stent complications. J Invasive Cardiol 1998;10:385-95.
105. Orford JL, Lennon R, Melby S, Fasseas P, Bell MR, Rihal CS et al. Frequency and correlates of coronary stent thrombosis in the modern era. J Am Coll Cardiol 2002;40:1507-72.
106. Hall P, Nakamura S, Maiello L, Itoh A, Blengino S, Martini G et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996;93:215-22.
107. Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-9.
108. Leon MB, Bairn DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study investigators. N Engl J Med 1998;339:1665-71.
109. Bertrand ME, Legrand V, Boland J, Fleck E, Bonnier J, Emmanuelson H et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation versus Aspirin and Ticlopidine (FANTASTIC) study. Circulation 1998;98:1597-603.
110. Urban P, Macaya C, Rupprecht HJ, Kiemeneij F, Emanuelsson H, Fontanelli A et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients in the Multicenter Aspirin and Ticlopidine Trial after Intra-coronary Stenting (MATTIS). Circulation 1998;98:2126-32.
111. Bhatt DL, Bertrand ME, Berger PB, L'Allier PL, Moussa I, Moses JW et al. Meta-analysis or randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol 2002;39:9-14.
112. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G et al. Intracoronary stenting without anticoagulation accomplished with ultrasound guidance. Circulation 1995;91:1676-88.
113. Nakamura S, Hall P, Gaglione A, Tiecco F, Di Maggio M, Maiello L et al. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation. J Am Coll Cardiol 1997;29:21-7.
114. Karrillon G, Morice MC, Benveniste E, Bunouf P, Aubry P, Cattan S et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. Circulation 1996;94:1519-27.
115. Moussa I, DiMario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 1997;29:6-12.
116. Wong P, Lau KW, Lim YL, Oesterle SN. Catheterization curriculum: stent placement for non-STRESS/BENESTENT lesions: a critical review. Catheter Cardiovasc Interv 2000;51:223-33.
117. Koning R, Eltchaninoff H, Commeau P, Khalife K, Gilard M, Lipiecki J et al. for the BESMART (BeStent in Small Arteries) Trial Investigators. Stent Placement compared with balloon angioplasty for small coronary arteries. Circulation 2001;104:1604-8.
118. Kastrati A, Schomig A, Dirschinger J, Mehilli J, Dotzer F, von Welser N et al. for the ISAR-SMART Investigators. A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery Disease. Circulation 2000;102:2593-8.
119. Savage MP, Fischman DL, Rake R, Leon MB, Schatz RA, Penn I et al. for the Stent Restenosis Study (STRESS) Investigators. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries. J Am Coll Cardiol 1998;31:307-11.
120. Akiyama T, Moussa I, Reimers B, Ferraro M, Kobayashi Y, Blengino S et al. Angiographic and clinical outcome following coronary stenting of small vessels. J Am Coll Cardiol 1998;32:1610-8.
121. Elezi S, Kastrati A, Neumann FJ, Hadamitzky M, Dirschinger J, Schomig A. Vessel size and long-term outcome after coronary stent placement. Circulation 1998;98:1875-80
122. Al Suwaidi JA, Tey W, Williams DO, Laskey WK, Cohen HA, Detre KM et al. Comparison of immediate and one-year outcome after coronary angioplasty of narrowing <3 mm with those >=3mm (The National Heart, Lung, and blood Institute Dynamic registry). Am J Cardiol 2001;87:680-6.
123. Kornowski R, Bhargava B, Fuchs S, Lansky AJ, Satler LF, Pichard AD et al. Procedural results and late clinical outcomes after percutaneous interventions using long (>25 mm) versus short (<20 mm) stents. J Am Coll Cardiol 2000;35:612-8.
124. Briguori C, Nishida T, Adamian M, Albiero R, Anzuini A, Di Mario C et al. Coronary stenting versus balloon angioplasty in small coronary artery with complex lesions. Catheter Cardiovasc Interv 2000;50:390-7.
125. Lemos PA, Martinez EE, Quintella E, Harrell LC, Ramires JA, Ribeiro EE et al. Stenting vs. balloon angioplasty with provisional stenting for the treatment of vessels with small reference diameter. Catheter Cardiovasc Interv 2002;55:309-14.
126. Goudreau E, DiSciasio G, Kelly K, Vetrovec GW, Cowley MJ. Coronary angioplasty of diffuse coronary artery disease. Am Heart J 1991;121:12-9.
127. Antonucci D, Valenti R, Santoro GM, Bolognese L, Trapani M, Fazzini PF.
128. Schalij MJ, Udayachalerm W, Oemrawsingh P, Jukema JW, Reiber JH, Bruschke AV. Stenting of long coronary artery lesions: initial angiographic results and 6-month clinical outcome of the micro stent II-XL. Catheter Cardiovasc Interv 1999;48:105-12.
129. obayashi Y, De Gregorio J, Kobayashi N, Akiyama T, Reimers B, Finci L et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999;34:651-9.
130. Di Sciasio G, Patti G, Nasso G, Manzoli A, D'Ambrosio A, Abbate A. Early and long-term results of stenting diffuse coronary artery disease. Am J Cardiol 2000;86: 1166-70.
131. Tuzcu EM, Berkalp B, De Franco AC, Ellis SG, Goormastic M, Whitlow PL et al. The dilemma of diagnosing coronary calcification: angiography versus intravascular ultrasound. J Am Coll Cardiol 1996;27: 832-8.
132. Warth DC, Leon MB, O'Neill W, Zacca N, Polissar NL, Buchbinder M. Rotational atherectomy multicenter registry: acute results and 6-month angiographic follow-up in 709 patients. J Am Coll Cardiol 1994;24:641-8.
133. Hoffmann R, Mintz GS, Kent KM, Pichard AD, Satler LF, Popma JJ et al. Comparative early and nine-month results of rotational atherectomy, stents and the combination of both for calcified lesions in large coronary arteries. Am J Cardiol 1998;81:552-7.
134. Litvack F, Eigler N, Margolis J, Rothbaum D, Bresnahan JF, Holmes D et al. Percutaneous excimer laser coronary angioplasty: results of the first consecutive 3,000 patients. J Am Coll Cardiol 1994;23:323-9.
135. Ahmed W, Al-Anazi MM, Bittl JA. Excimer laser-facilitated angioplasty for undilatable coronary narrowing. Am J Cardiol 1996;78:1045-7.
136. Vetrovec GW, Cowley MJ, Wolfgang TC, Ducey KC. Effects of percutaneous transluminal coronary angioplasty on lesion-associated branches. Am Heart J 1985;109:921-5.
137. Pinkerton CA, Slack JD, van Tassel JW, Orr CM. Angioplasty for dilatation of complex coronary artery bifurcation stenosis. Am J Cardiol 1985;55:1626-8.
138. Meier B. Kissing balloon coronary angioplasty. Am J Cardiol 1984;54:918-20.
139. Al Suwaidi JA, Yeh W, Cohen HA, Detre KM, Williams DO, Holmes DR Jr. immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI Dynamic Registry). Am J Cardiol 2001;87:1139-44.
140. George BS, Myler RK, Stertzer SH, Clark DA, Cote G, Shaw RE et al. Balloon angioplasty of coronary bifurcation lesions: the kissing balloon technique. Catheter Cardiovasc Interv 1986;12:124-38.
141. Myler RK, McConahay DR, Stertzer SH, Johnson W, Cumberland DC, Boucher RA et al. Coronary bifurcation stenoses: the kissing balloon probe technique via a single guiding catheter. Catheter Cardiovasc Diagn 1989;16:267-78.
142. Colombo A, Gagilone A, Nakamura S, Finci I.: "Kissing" stents for bifurcational coronary lesion. Catheter Cardiovasc Diagn 1993;30:327-30.
143. Nakamura S, Hall P, Maiello L, Colombo A. Techniques for Palmaz-Schatz stent deployment in lesions with a large side branch. Catheter Cardiovasc Diagn 1995;34: 353-61.
144. Satler LF, Mintz GS, Pichard AD, Kent KM. Bifurcation disease: to treat or not to treat. Catheter Cardiovasc Interv 2000;50:411-2.
145. Colombo A, Stankovic G, Corvaja N, Corvaja N, Liistro F, Airoldi F et al. Modified T-stenting techniques with crushing for bifurcation lesions: immediate results and 30-day outcome. Catheter Cardiovasc Interv 2003;60:145-51.
146. Caputo RP, Chafizadeh ER, Stoler RC, Lopez JJ, Cohen DJ, Kuntz RE et al. Stent jail: a minimum security prison. Am J Cardiol 1996;77:1226-9.
147. Al Suwaidi JA, Berger PB, Rihal CS, Garratt KN, Bell MR, Ting HH et al. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol 2000;35:929-36.
148. Chevalier B, Glatt B, Royer T, Guyon P. Placement of coronary stents in bifurcation lesions by the 'culotte' technique. Am J Cardiol 1998;82:943-9.
149. Carrie D, Elbaz M, Gregoire D, Saint-Cricq F, Dugrand P, Fourcade et al. Coronary stenting of bifurcation lesions using "T' or "Reverse Y" configuration with Wiktor stent. Am J Cardiol 1998;82:1418-21.
150. DiMario C, Colombo A. Trousers-stents: how to choose the right size and shape? Catheter Cardiovasc Interv 1997;41:197-9.
151. Aliabadi D, Tilli FV, Bowers TR, Benzuly KH, Safian RD, Goldstein JA et al. Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting. Am J Cardiol 1997;80: 994-7.
152. Yamshita T, Nishida T, Adamian MG, Briguori C, Vaghetti M, Corvaja N et al. Bifurcation lesions: two stents versus one stent- Immediate and follow-up results. J Am Coll Cardiol 2000;35:1145-51.
153. Hoye A, Van Der Giessen WJ. New approaches to osteal and bifurcation lesions. J Interv Cardiol 2004;17: 397-403.
154. Sharma SK, Choudhury A, Lee J, Kim MC, Fisher E, Steinheimer AM et al. Simultaneous kissing stents (SKS) technique for treating bifurcation lesions in medium-to-large size coronary arteries. Am J Cardiol 2004;94:913-7.
155. Kobayashi Y, Colombo A, Adamian M, Nishida T, Moussa I, Moses JW et al. The skirt technique: a stenting technique to treat a lesion immediately proximal to the bifurcation (pseudobifurcation). Catheter Cardiovasc Interv 2000;51:347-51.
156. Carrie D, Karouny E, Chouairi S, Fuel J. "T"-shaped stent placement: a technique for the treatment of dissected bifurcation lesions. Catheter Cardiovasc Diagn 1996;37:311-3.
157. Kobayashi Y, Colombo A, Akkiyama T, Reimers B, Martini G, diMario C. Modified "T" stenting: a technique for kissing stents in bifurcational coronary lesion. Catheter Cardiovasc Diagn 1998;43:323-6.
158. Schampaert E, Fort S, Adelman AG, Schwartz L. The V-stent: a novel technique for coronary bifurcation stenting. Catheter Cardiovasc Diagn 1996;39:320-6.
159. Baim DS. Is bifurcation stenting the answer? Catheter Cardiovasc Diagn 1996;37:314-6.
160. Colombo A, Stankovic G, Orlic D, Corvaja N, Liistro F, Airoldi F et al. Modified T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcomes. Catheter Cardiovasc Interv 2003;60:145-51.
161. Pan M, Suarez de Lezo J, Medina A, Romero M, Segura J, Ramirez A et al. A Stepwise strategy for the stent treatment of bifurcated lesions. Catheter Cardiovasc Interv 2002;55:50-7.
162. Melikian N, DiMario C. Treatment of bifurcation coronary lesions: a review of current techniques and outcome. J Interv Cardiol 2003;16:507-13.
163. Lefevre T, Louvard Y, Morice M-C, Dumas P, Loubeyre C, Benslimane A et al. Stenting of bifurcation lesions; classification, treatments, and results. Catheter Cardiovasc Interv 2000;49:274-83.
164. Rubartelli P, Niccoli L, Verna E, Giachero C, Zimarino M, Fontanelli A et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOC trial. Gruppo Italiano di Studio sullo Stent nelle Occlusioni Coronariche. J Am Coll Cardiol 1998;32:90-6.
165. Buller CE, Dzavik V, Carere RG, Mancini GB, Barbeau G, Lazzam C et al. Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). Circulation 1999;100:236-42.
166. Goldberg SL, Colombo A, Maiello L, Borrione M, Finci L, Almagor Y. Intracoronary stent insertion after balloon angioplasty of chronic total occlusions. J Am Coll Cardiol 1995;26:713-9.
167. Ozaki Y, Violaris AG, Hamburger J, Melkert R, Foley D, Keane D et al. Short- and long-term clinical and quantitative angiographic results with the new, less shortening Wallstent for vessel reconstruction in chronic total occlusion: a quantitative angiographic study. J Am Coll Cardiol 1996;28:354-60.
168. Mori M, Kurogane H, Hayashi T, Yasaka Y, Ohta S, Kajiya T et al. Comparison of results of intracoronary implantation of the Plamaz-Schatz stent with conventional balloon angioplasty in chronic total coronary arterial occlusion. Am J Cardiol 1996;78:985-9.
169. Hoher M, Wohrle J, Grebe OC, Kochs M, Osterhues HH, Hombach V et al. A randomized trial of elective stenting after balloon recanalization of chronic total occlusions. J Am Coll Cardiol 1999;34:722-9.
170. Sirnes PA, Golf S, Myreng Y, Molstad P, Albertsson P, Mangschau A et al. Sustained benefit of stenting chronic coronary occlusion: long-term clinical follow-up of the Stenting in Chronic Coronary Occlusion (SICCO) study. J Am Coll Cardiol 1998;32:305-10.
171. Sirnes PA, Golf S, Myreng Y, Molstad P, Emanuelsson H, Albertsson P et al. Stenting in Chronic Coronary Occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996;28:1444-51.
172. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE et al. on behalf of the Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) trial investigators, randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-90.
173. Grube E, Gerckens U, Yeung AC, Rowold S, Kirchhof N, Sedgewick J et al. Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection. Circulation 2001;104:2436-41.
174. Stone GW, Roger C, Ramee S, White C, Kuntz RE, Popma JJ et al. Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy. J Am Coll Cardiol 2002;40:1882-8.
175. rd, Hollman J, Ischinger T, Meier B et al. Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery. J Am Coll Cardiol 1983;2:745-54.
176. Piana RN, Moscucci M, Cohen DJ, Kugelmass AD, Senerchia C, Kuntz RE et al. Palmaz-Schatz stenting for treatment of focal vein graft stenosis: immediate results and long-term outcome. J Am Coll Cardiol 1994;23:1296-304.
177. rd, Werner JA et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997;337:740-7.
178. Antoniucci D, Santoro G, Bolognese L, Valenti R, Trapani M, Fazzini PF. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction. Results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) Trial. J Am Coll Cardiol 1998;31:1234-9.
179. Stone GW, Brodie BR, Griffin LL, Morice MC, Constantini C, St. Goar FG et al. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI Stent Pilot Trial. J Am Coll Cardiol 1998;31:23-30.
180. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A et al. for the Stent Primary Angioplasty in Myocardial Infarction Study Group. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999;341:1949-56.
181. The EPISTENT Investigators. Randomized placebo-controlled and balloon-angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet 1998;352:87-92.
182. Lefkovits J, Ivanhoe RJ, Califf RM, Bergelson BA, Anderson KM, Stoner GL et al. for the EPIC Investigators. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (Abciximab) on acute and six -month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1996;77:1045-51.
183. Brener SJ, Barr LA, Burchenal JEB, Katz S, George BS, Jones AA et al. on behalf of the ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 1998;98:734-41.
184. Antoniucci D, Valenti R, Migliorini A, Moschi G, Trapani M, Dovellini EV et al. Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation. Am J Cardiol 2002;90:353-7.
185. Chan AW, Chew DP, Bhatt DL, Moliterno DJ, Topol EJ, Ellis SG. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 2002;89:132-6.
186. Antoniucci D, Valenti R, Santoro GM, Bolognese L, Trapani M, Moschi G et al. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and Long term survival. J Am Coll Cardiol 1998;31:294-300.
187. Sousa JE, Costa MA, Abizaid AC, Rensing BJ, Abizaid AS, Tanajura LF et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents. Circulation 2001;104:2007-11.
188. Degertekin M, Serruys PW, Foley AP, Tanabe K, Regar E, Vos J et al. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 2002;106:1610-3.
189. Morice M-C, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M et al. for the RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
190. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C et al. for the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
191. Park S-J, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003;348:1537-45.
192. Hong M-K, Mintz GS, Lee CW, Song JM, Han KH, Kang DH et al. Paclitaxel coating reduces in-stent Intimal hyperplasia in human coronary arteries. Circulation 2003;107:517-20.
193. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT et al. for the TAXUS-IV investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31.
194. Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ. A hierarchical Bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet 2004;364:583-91.
195. Lemos PA, Serruys PW, an Domburg RT, Saia F, Arampatzis CA, Hoye A et al. Unrestricted utilization of Sirolimus-eluting stents compared with conventional bare stent implantation in the "Real World": The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry. Circulation 2004;109:190-5.
196. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Fache J et al. for the ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or Paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary restenosis. A randomized controlled trial. JAMA 2005;293:165-71.
197. Lemos PA, Lee C-H, Degertekin M, Saia F, Tanabe K, Arampatzis CA et al. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes. J Am Coll Cardiol 2003;41:2093-9.
198. Lemos PA, Saia F, Hofma SH, Daemen J, Ong AT, Arampatzis CA et al. Short and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 2004;43:704-8.
199. Saia F, Lemos PA, Lee C-H, Arampatzis CA, Hoye A, Degertekin M et al. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction. A clinical and angiographic Study. Circulation 2003;108:1927-9.
200. Sawhney N, Moses JW, Leon MB, Kuntz RF, Popma JJ, Bachinsky W et al. Treatment of left anterior descending coronary artery disease with Sirolimus-eluting stents. Circulation 2004;110:374-9.
201. Hoye A, Lemos PA, Arampatzis CA, Saia F, Tanabe K, Degertekin M et al. Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease. J Invasive Cardiol 2004;16:230-3.
202. Ge L, Iakovu GM, Sangiorgi GM, Chieffo A, Melzi G, Cosgrave J et al. Treatment of saphenous vein graft lesions with drug-eluting stents immediate and midterm outcome. J Am Coll Cardiol 2005;45:989-94.
203. Ong ATL, Serruys PW, Aoki J, Hoye A, van Mieghem CA, Rodriguez-Granillo GA et al. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population. One-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) Registry. J Am Coll Cardiol 2005;45:1135-41.
204. Hoye A, Tanabe K, Lemos PA, Aoki J, Saia F, Arampatzis C et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. J Am Coll Cardiol 2004;43:1954-8.
205. Degertekin M, Regar E, Tanabe K, Smits PC, van der Giessen WJ, Carlier SG et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis. J Am Coll Cardiol 2003;41:184-9.
206. Cohen DJ, Bakhai A, Shi C, Githiora L, Lavelle T, Berezin RH et al. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-eluting Balloon Expandable Stent in the Treatment of Patients with Denovo native Coronary Artery Lesions (SIRIUS) Trial. Circulation 2004;110:508-14.
207. Saia F, Lemos PA, Sianos G, Degertekin M, Lee CH, Arampatzis CA et al. Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy. Am J Cardiol 2003;92:200-3.
208. Goy J-J, Urban P, Seydoux C, De Benedetti E, Stauffer JC. Use of sirolimus-eluting stents in routine clinical practice. Catheter Cardiovasc Interv 2004;62:26-29; discussion 62.
209. Columbo A, Iakovou I. Drug-eluting stents: the new gold standard for percutaneous coronary revascualrization. Eur Heart J 2004;25:895-7.
210. Pan M, Lezo JS, Medina A, Romero M, Segura J, Pavlovic D et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of simple versus complex strategy. Am Heart J 2004;148:857-64.
211. Ormiston JA, Currie E, Webster MWI, Kay P, Ruygrok PN, Stewart JT et al. Drug-eluting stents for coronary bifurcations: insights into the crush technique. Catheter Cardiovasc Interv 2004;63:332-6.
212. Columbo A. Bifurcational lesions and the 'crush' technique: understanding why it works and why it doesn't-a kiss is not just a kiss. Catheter Cardiovasc Interv 2004;63:337-8.
213. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR Jr, Spanos V et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004;109:1244-9.
214. Tanabe K, Hoye A, Lemos PA, Aoki J, Arampatzis CA, Saia F et al. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. Am J Cardiol 2004;91:115-8.
215. Block PC, Peterson EC, Krone R, Kesler K, Hannan E, O'Connor GT et al. Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection. J Am Coll Cardiol 1998;32:275-82.
216. Bergelson BA, Jacobs AK, Cupples A, Ruocco NA Jr, Kyller MG, Ryan TJ et al. Prediction of risk for hemodynamic compromise during percutaneous transluminal coronary angioplasty. Am J Cardiol 1992;70: 1540-5.
217. Ellis SG, Myler RK, King SB 3rd, Douglas JS Jr, Topol EJ, Shaw RE et al. Causes and correlates of death after unsupported coronary angioplasty: implications for use of angioplasty and advanced support techniques in high-risk settings. Am J Cardiol 1991;68:1447-51.
218. Tenaglia AN, Fortin DF, Califf RM, Frid DJ, Nelson CL, Gardner L et al. Predicting the risk of abrupt vessel closure after angioplasty in an individual patient. J Am Coll Cardiol 1994;24:1004-11.
219. Holmes DR, Selzer F, Johnston JM, Kelsey SF, Holubkov R, Cohen HA et al. Modeling and risk prediction in the current era of interventional cardiology: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circulation 2003;107:1871-6.
220. Huber MS, Mooney JF, Madison J, Mooney MR. Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol 1991;68:467-71.
221. Suh WW, Grill DE, Holmes DR, Bell MR, Berger P, Garrett KN. Clinical, angiographic, and procedural correlates of abrupt vascular closure during coronary Intervention: a 10-year experience at Mayo Clinic. Catheter Cardiovasc Interv 1999;47:391-5.
222. Clark RE for the committee. Definitions of terms of the Society of Thoracic Surgeons National Cardiac Surgery Database. Ann Thorac Surg 1994;58:271-3.
223. Edwards FH, Clark RE, Schwartz M. Coronary artery bypass grafting. The Society of Thoracic Surgeons National Database Experience. Ann Thorac Surg 1994;57:12-9.
224. Hannan EL, Kilburn H, O'Donnell JF, Lukacik G, Shields EP. Adult Open Heart Surgery in New York State. An analysis of risk factors and hospital mortality rates. JAMA 1990;264:2768-74.
225. Hannan EL, Kilburn H, Racz M, Shields E, Chassin MR. Improving the outcomes of Coronary Artery Bypass Surgery in New York State. JAMA 1994;271:761-6.
226. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A Clinical Severity Score. JAMA 1992;267:2344-8.
227. Jones RH, Hannan EL, Hammermeister KE, DeLong ER, O'Connor GT, Luepker RV et al. for the Working Group Panel on the Cooperative CABG Database Project. Identification of preoperative variables needed for adjustment of short-term mortality after coronary artery bypass graft surgery. J Am Coll Cardiol 1996;28:1478-87.
228. Weiman D, Ramanathan K, Morrison DA. Chronic Pulmonary Disease. In: Morrison DA, Serruys PW, editors. High-Risk Cardiac Revascularization and Clinical Trials. London: Martin Dunitz; 2002. p.363-72.
229. Braun SR, Birnbaum MI, Chopra PS. Pre and postoperative pulmonary function abnormalities in coronary artery revascularization surgery. Chest 1978;73:318.
230. Jenkins SC, Soutar SA, Forsyth A, Keates JR Moxham I. Lung function after coronary artery surgery using the internal mammary artery and the saphenous vein. Thorax 1989;44:209-11.
231. Shapira N, Zabatino SM, Ahmed S, Murphy DM, Sullivan D, Lemole GM. Determinants of pulmonary function in patients undergoing coronary bypass operations. Ann Thorac Surg 1990;50:268-73.
232. Kroenke K, Lawrence VA, Theroux JF, Tuley MR. Operative risk in patients with severe obstructive pulmonary disease. Arch Intern Med 1992;152:967-71.
233. Cohen A, Katz M, Katz R, Hauptman E, Schachner A. Chronic obstructive pulmonary disease in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1995;109:574-81.
234. Wall GW, Swinburne AJ, Fedullo Al, Lee DK, Shayne D. Effect of age and preoperative airway obstruction on lung function after coronary artery bypass grafting. Ann Thorac Surg 1993;56:104-7.
235. Williams CD, Brenowits JB. Prohibitive lung function and major surgical procedures. Am J Surg 1976;132: 763-6.
236. Zibrak JD, O'Donnel CR, Haley K, et al. Predictive factors for pulmonary complications following CABG surgery. Chest 1990;98:895.
237. Bevelaqua F, Garritan S, Haas F, Salazar-Schicchi J, Axen K, Reggiani JL. Complications after cardiac operations in patients with severe pulmonary impairment. Am Thorac Surg 1990;50:602-6.
238. Milano CA, Kesler K, Archibald N, Sexton DJ, Jones RT. Mediastinitis after coronary artery bypass graft surgery. Circulation 1995;92:2245-51.
239. Pett SB Jr. Renal function and high-risk coronary artery procedures. In: Morrison DA, Serruys PW, editors: High-Risk Cardiac Revascularization and Clinical Trials. London: Martin Dunitz; 2002.p.415-24.
240. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-64.
241. Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 2003;289:553-8.
242. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ, Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-9.
243. Morrison DA, Barbiere CC, Johnson R, Marshall G. Fullerton D, Hammermeister KE et al. Salvage angioplasty: an alternative to high-risk surgery for unstable angina. Catheter Cardiovasc Diagn 1992;27:169-78.
244. Morrison DA, Sacks J, Grover F, Hammermeister KE. Effectiveness of percutaneous transluminal coronary angioplasty for patients with medically refractory rest angina pectoris and high risk of adverse outcomes with coronary artery bypass grafting. Am J Cardiol 1995;75:237-40.
245. Morrison DA. Summary of "high risk" and "prohibitive risk" for surgery or angioplasty in unstable angina. In: Morrison DA, Serruys PW, editors. Medically Refractory Rest Angina. New York: Marcel Dekker; 1992.p.385-401.